Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
FULC
FULC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FULC News
Fulcrum Therapeutics Shares Plunge 50% After FDA Safety Concerns
Jun 05 2026
Globenewswire
Fulcrum Therapeutics Shares Plunge 50% After FDA Safety Concerns
Jun 03 2026
PRnewswire
Fulcrum, Heron, and MicroVision Stocks Plunge to Record Lows
Jun 03 2026
stocktwits
Fulcrum Therapeutics Faces FDA Safety Issues Leading to Program Termination
Jun 02 2026
PRnewswire
Surge in Options Trading Volume for Broadcom and Fulcrum
Jun 02 2026
NASDAQ.COM
Fulcrum Therapeutics Under Investigation for Securities Violations
Jun 02 2026
Globenewswire
Investigation Launched into Fulcrum Therapeutics Following Program Discontinuation
Jun 02 2026
Globenewswire
Biotech Stocks Show Strong Pre-Market Moves
Jun 02 2026
NASDAQ.COM
Fulcrum Therapeutics Abandons Sickle-Cell Drug Development Amid FDA Concerns
Jun 02 2026
Newsfilter
Fulcrum Therapeutics Halts pociredir Development Amid FDA Safety Concerns
Jun 02 2026
seekingalpha
Fulcrum Discontinues Pociredir Program Amid FDA Concerns
Jun 02 2026
NASDAQ.COM
Fulcrum Discontinues pociredir Development, Shares Plunge 49%
Jun 01 2026
stocktwits
Fulcrum Therapeutics Grants Stock Options to New Employees
May 08 2026
Newsfilter
Fulcrum (FULC) Q1 2026 Earnings Transcript
Apr 27 2026
NASDAQ.COM
Fulcrum Therapeutics Q1 Earnings Beat Expectations
Apr 27 2026
seekingalpha
Fulcrum Therapeutics Grants Stock Options to New Employee
Mar 06 2026
Newsfilter
Show More News
